0001140361-11-057471.txt : 20111214
0001140361-11-057471.hdr.sgml : 20111214
20111214172915
ACCESSION NUMBER: 0001140361-11-057471
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111212
FILED AS OF DATE: 20111214
DATE AS OF CHANGE: 20111214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIRK THOMAS F
CENTRAL INDEX KEY: 0001258258
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 111261827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0304
4
2011-12-12
0
0000722723
HANGER ORTHOPEDIC GROUP INC
HGR
0001258258
KIRK THOMAS F
2616 LIGHTHOUSE BEND DR
PONTE VEDRA BEACH
FL
32082
1
1
0
0
President and CEO
Common Stock
2011-12-12
4
M
0
350000
6.02
A
737145
D
Common Stock
2011-12-12
4
F
0
127158
16.57
D
609987
D
Common Stock
2011-12-13
4
S
0
81876
16.4886
D
528111
D
Option to Buy
6.02
2011-12-12
4
M
0
350000
0
D
2003-01-02
2012-01-02
Common Stock
350000
0
D
Option to Buy
13.50
2004-01-02
2013-01-02
Common Stock
100000
100000
D
Option to Buy
15.67
2005-01-02
2014-01-02
Common Stock
100000
100000
D
Option to Buy
8.08
2006-01-03
2015-01-03
Common Stock
100000
100000
D
The shares of common stock were sold to cover taxes incurred as a result of the exercise of stock options.
These shares were sold at a range of sale prices from $16.31 to $16.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares which total 20,000 shares of stock from an initial grant of 20,000 shares of restricted stock made on March 25, 2011, (ii) unvested restricted shares and fully vested shares which total 103,700 shares of stock from an initial grant of 115,000 shares of restricted stock and performance shares made on March 30, 2010, (iii) unvested restricted shares and fully vested shares that total 76,234 shares of stock from an initial grant of 107,730 shares of restricted stock and performance shares made on November 13, 2008, (iv) fully vested shares that total 75,036 shares of stock from an initial grant of 120,000 shares of restricted stock and performance shares made on August 9, 2007, and (v) fully vested shares that total 98,175 shares of stock from an initial grant of 110,000 shares of restricted stock made on June 12, 2006.
All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
This option vested over a four-year period from the date of grant and is now fully vested.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas F. Kirk
2011-12-14